iSpecimen (ISPC) Gross Profit (2020 - 2026)

iSpecimen (ISPC) has reported Gross Profit for 7 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gross Profit fell 295.15% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$2.3 million (down 160.47% YoY), while the FY2025 annual figure was -$366503.0, down 108.77% from the prior year.
• Gross Profit came in at -$1.4 million for Q1 2026 at iSpecimen, down from -$1.1 million in the prior quarter.
• The five-year high for Gross Profit was $2.0 million in Q4 2022, with the low at -$1.4 million in Q1 2026.
• Average Gross Profit over 5 years is $932813.4, with a median of $1.3 million recorded in 2024.
• Across the five-year window, Gross Profit soared 175.06% in 2024 and sank 642.74% in 2025, its largest moves.
• Year by year, Gross Profit stood at $2.0 million in 2022, then retreated by 1.69% to $2.0 million in 2023, then slumped by 90.1% to $199241.0 in 2024, then tumbled by 642.74% to -$1.1 million in 2025, then dropped by 28.2% to -$1.4 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered -$1.4 million, -$1.1 million, and -$98001.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.